Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging. [PDF]
Hu M +12 more
europepmc +1 more source
Experimental and translational models of Alzheimer's disease: From neurodegeneration to novel therapeutic insights. [PDF]
Khan N, De S, Boddu S, Pravala N.
europepmc +1 more source
Zolpidem restores sleep and decreases amyloid in a mouse model. [PDF]
Yu L +6 more
europepmc +1 more source
Double-edged role of N6-methyladenosine reader YTH structural domain family protein 2 in neurological disorders: Molecular mechanisms and translational prospects. [PDF]
Liu YM, Liu M, Yuan H, Li B.
europepmc +1 more source
Physiological Implications of Pancreatic Amyloid Polypeptide Aggregation and Its Inhibition by Melatonin. [PDF]
Yoo YM, Joo SS.
europepmc +1 more source
Glycyrrhizic Acid Attenuates Aβ<sub>42</sub>-Induced Neurodegeneration Through Coordinated Regulation of Oxidative Stress, Synaptic Markers, and Key Alzheimer's Signaling Pathways. [PDF]
Amrutha S, Prasad TSK, Modi PK.
europepmc +1 more source
Editorial: Cellular and molecular pathologies of Alzheimer's disease: understanding the link between different etiological factors for therapeutic exploitation. [PDF]
Sabbir MG.
europepmc +1 more source
TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease. [PDF]
Yang NV +8 more
europepmc +1 more source
Candidate Key Proteins in Thalamo-Amygdala Signaling in Tinnitus: A Bioinformatics Study. [PDF]
Gross J, Knipper M, Mazurek B.
europepmc +1 more source
RNA-binding activity of PHGDH drives amyloid-beta production in a human brain organoid model of sporadic Alzheimer's disease. [PDF]
Chen J +6 more
europepmc +1 more source

